A Population Approach to Disease Management: Hepatitis C Direct-Acting Antiviral Use in a Large Health Care System

BACKGROUND: The introduction of the first direct-acting antiviral agents (DAAs) for the treatment of hepatitis C virus (HCV), telaprevir and boceprevir, marked a unique event in which 2 disease-changing therapies received FDA approval at the same time. Comparative safety and effectiveness data in re...

Descripción completa

Detalles Bibliográficos
Autores principales: Belperio, Pamela S., Backus, Lisa I., Ross, David, Neuhauser, Melinda M., Mole, Larry A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2014
Materias:
Formulary Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438086/
https://www.ncbi.nlm.nih.gov/pubmed/24856591
http://dx.doi.org/10.18553/jmcp.2014.20.6.533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438086/
https://www.ncbi.nlm.nih.gov/pubmed/24856591
http://dx.doi.org/10.18553/jmcp.2014.20.6.533

Ejemplares similares